Scholarly Index
Patricia Pautier
Institut Gustave Roussy; 13,839 total citations; 325 total publications; best world rank #237
Institut Gustave Roussy
13,839Total citations
325Total publications
51H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 502 | FR 17 | 97.95 |
| Sarcoma Diagnosis and Treatment | Lifetime | 674 | FR 37 | 97.64 |
| Uterine Myomas and Treatments | Lifetime | 313 | FR 18 | 97.85 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 429 | FR 19 | 97.92 |
| PARP inhibition in cancer therapy | Lifetime | 863 | FR 44 | 91.65 |
| Vascular Tumors and Angiosarcomas | Lifetime | 926 | FR 49 | 90.12 |
| Chromatin Remodeling and Cancer | Lifetime | 754 | FR 47 | 85.64 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 278 | FR 13 | 95.69 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 335 | FR 33 | 93.94 |
| PARP inhibition in cancer therapy | 2021-2025 | 237 | FR 18 | 92.44 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 464 | FR 28 | 93.60 |
| Management of metastatic bone disease | 2021-2025 | 383 | FR 13 | 83.76 |
| BRCA gene mutations in cancer | 2021-2025 | 881 | FR 19 | 82.45 |
| Uterine Myomas and Treatments | 2021-2025 | 673 | FR 36 | 83.19 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 332 | FR 34 | 74.23 |